Utilization of Pharmacological Ascorbate to Enhance Hydrogen Peroxide-Mediated Radiosensitivity in Cancer Therapy

Interest in the use of pharmacological ascorbate as a treatment for cancer has increased considerably since it was introduced by Cameron and Pauling in the 1970s. Recently, pharmacological ascorbate has been used in preclinical and early-phase clinical trials as a selective radiation sensitizer in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehdi, Zain, Petronek, Michael S., Stolwijk, Jeffrey M., Mapuskar, Kranti A., Kalen, Amanda L., Buettner, Garry R., Cullen, Joseph J., Spitz, Douglas R., Buatti, John M., Allen, Bryan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509557/
https://www.ncbi.nlm.nih.gov/pubmed/34639220
http://dx.doi.org/10.3390/ijms221910880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509557/
https://www.ncbi.nlm.nih.gov/pubmed/34639220
http://dx.doi.org/10.3390/ijms221910880

Ejemplares similares